StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.77−0.07 (-2.46%)

Close on Nov 18, 2026Market cap $546.32MP/E –Yield –

Wave Life Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Wave Life Sciences's revenue for the twelve months ending Sep 30, 2026 was $70.92M. For fiscal 2025 it was $42.73M, down 60.5% from the year before. Over ten years it grew 75.7% a year on average. The highest annual figure on record is $113.31M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$42.73M-60.5%
FY2024Dec 31, 2024$108.30M-4.4%
FY2023Dec 31, 2023$113.31M+3005.1%
FY2022Dec 31, 2022$3.65M-91.1%
FY2021Dec 31, 2021$40.96M+104.0%
FY2020Dec 31, 2020$20.08M+25.6%
FY2019Dec 31, 2019$15.98M+10.9%
FY2018Dec 31, 2018$14.41M+270.3%
FY2017Dec 31, 2017$3.89M+256.5%
FY2016Dec 31, 2016$1.09M+618.4%
FY2015Dec 31, 2015$152.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$13.16M+72.9%
Q2 FY2026Jun 30, 2026$2.27M-73.9%
Q1 FY2026Mar 31, 2026$38.25M+316.9%
Q4 FY2025Dec 31, 2025$17.25M-12.4%
Q3 FY2025Sep 30, 2025$7.61M-39.3%
Q2 FY2025Jun 30, 2025$8.70M-70.1%
Q1 FY2025Mar 31, 2025$9.18M-81.4%
Q2 FY2024Jun 30, 2024$19.69M-10.9%
Q1 FY2024Mar 31, 2024$12.54M-3.0%
Q4 FY2023Dec 31, 2023$29.06M+2245.1%
Q3 FY2023Sep 30, 2023$49.21M+17168.1%
Q2 FY2023Jun 30, 2023$22.11M+5794.9%
Q1 FY2023Mar 31, 2023$12.93M+638.8%
Q4 FY2022Dec 31, 2022$1.24M-29.8%
Q3 FY2022Sep 30, 2022$285.00K-99.2%
Q2 FY2022Jun 30, 2022$375.00K-86.5%
Q1 FY2022Mar 31, 2022$1.75M-81.5%
Q4 FY2021Dec 31, 2021$1.77M-48.8%
Q3 FY2021Sep 30, 2021$36.42M+1103.3%
Q2 FY2021Jun 30, 2021$2.78M-33.3%
Q4 FY2020Dec 31, 2020$9.44M+293.3%
Q3 FY2020Sep 30, 2020$3.45M+17.8%
Q2 FY2020Jun 30, 2020$3.03M-60.3%
Q1 FY2020Mar 31, 2020$4.16M+37.5%
Q4 FY2019Dec 31, 2019$2.40M-33.7%
Q3 FY2019Sep 30, 2019$2.93M-34.8%
Q2 FY2019Jun 30, 2019$7.63M+56.3%
Q1 FY2019Mar 31, 2019$3.03M+112.8%
Q4 FY2018Dec 31, 2018$3.62M+229.7%
Q3 FY2018Sep 30, 2018$4.49M+241.7%
Q2 FY2018Jun 30, 2018$4.88M+344.8%
Q1 FY2018Mar 31, 2018$1.42M+271.3%
Q4 FY2017Dec 31, 2017$1.10M+62.4%
Q3 FY2017Sep 30, 2017$1.32M–
Q2 FY2017Jun 30, 2017$1.10M–
Q1 FY2017Mar 31, 2017$383.00K–
Q4 FY2016Dec 31, 2016$676.00K–

More Wave Life Sciences figures

See a number that looks wrong?